webcast recording:

agenda

1:00-1:10 Opening Remarks  |  Cat Paciente, Momcology

1:10-1:25 Welcome Remarks  |  Rea Blakey, Associate Director, External Outreach and Engagement, Oncology Center of Excellence, FDA

1:25-1:40 Chemotherapy-Induced Hearing Loss Clinical Overview  |  Kristy Knight, MS, CCC-A, FAAA, Associate Professor, Audiology Training Coordinator, Oregon LEND Program, Child Development and Rehabilitation Center, Doernbecher Children’s Hospital, Oregon Health and Science University

1:40-1:50 Introduction and Meeting Overview  |  James Valentine, JD, MHS, Meeting Moderator

1:50 - 2:00 Audience & Remote Demographic Polling

2:00-3:10 Topic 1: Living with Chemotherapy-Induced Hearing Loss 

• Panel (25 minutes)

• Audience & Remote Polling (10 minutes)

• Moderated Audience Discussion (35 minutes)

3:10 - 3:25 Break

3:25-3:35 Challenges in Clinical Trial Design in Chemotherapy-Induced Hearing Loss  |  Greg Aune, MD, PhD, Assistant Professor, UT Health San Antonio-Greehey Children’s Cancer Research Institute

3:35-4:45  Topic 2: Current & Future Treatments from the Patient and Caregiver

• Panel (25 minutes)

• Audience & Remote Polling (10 minutes)

• Moderated Audience Discussion (35 minutes)

4:45-5:00 Meeting Summary |  Greg Reaman, MD, Associate Director for Pediatric Oncology, Oncology Center of Excellence, FDA

5:00-5:10 Closing Remarks & Next Steps  |  George Dahlman, CEO, Children’s Cause for Cancer Advocacy

Adjourn